Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 8;5(1):20180054.
doi: 10.1259/bjrcr.20180054. eCollection 2019 Feb.

A case of aortitis during cisplatin-based chemotherapy for cervical cancer

Affiliations

A case of aortitis during cisplatin-based chemotherapy for cervical cancer

Katharine Webb et al. BJR Case Rep. .

Abstract

A case of aortitis in a patient undergoing adjuvant cisplatin and topotecan chemotherapy for cervical cancer following presentation with pyrexia of unknown origin and raised inflammatory markers is presented. Although many chemotherapy agents are known to cause small vessel vasculitis and there are several reported cases of large vessel vasculitis following gemcitabine chemotherapy, there is only one previously described case of aortitis following cisplatin administration. This case is presented with corresponding CT and 18F-FDG PET-CT imaging with discussion of the literature regarding vasculitis and chemotherapy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Axial CT with i.v. contrast. Abnormal circumferential mural thickening is seen in the descending thoracic aorta (red arrow). Also, a small left pleural effusion is noted.
Figure 2.
Figure 2.
Axial CT with i.v. contrast. Abnormal circumferential mural thickening is seen in the aortic arch (red arrow).
Figure 3.
Figure 3.
Fused axial 18F-FDG PET-CT shows increased FDG avidity in the aortic wall corresponding to the mural thickening (red arrow). FDG, fludeoxyglucose.
Figure 4.
Figure 4.
Fused axial 18F-FDG PET-CT shows increased FDG avidity in the aortic wall corresponding to the mural thickening (red arrow). FDG, fludeoxyglucose.
Figure 5.
Figure 5.
(Left image) MIP sagittal 18F-FDG PET-CT shows increased FDG avidity in the aortic wall corresponding to the mural thickening. (Right image) Post therapy MIP Sagittal 18F-FDG PET-CT shows complete resolution of the abnormal metabolic activity in keeping with a metabolic response. MIP, maximum intensity projection.

References

    1. Töpel I, Zorger N, Steinbauer M. Inflammatory diseases of the aorta: part 1: non-infectious aortitis. Gefasschirurgie 2016; 21(Suppl 2): 80–6. doi: 10.1007/s00772-016-0143-9 - DOI - PMC - PubMed
    1. Töpel I, Zorger N, Steinbauer M. Inflammatory diseases of the aorta: part 2: infectious aortitis. Gefasschirurgie 2016; 21(Suppl 2): 87–93. doi: 10.1007/s00772-016-0142-x - DOI - PMC - PubMed
    1. Tanaka H, Kondo E, Kawato H, Kikukawa T, Toyoda N. Aortitis during intraarterial chemotherapy for cervical cancer. Int J Clin Oncol 2002; 7: 62–5. doi: 10.1007/s101470200008 - DOI - PubMed
    1. Eyre TA, Gooding S, Patel I, Moore N, Hatton C, Collins GP. Gemcitabine-induced large vessel vasculitis demonstrated by PET CT: a rare, important side effect. Int J Hematol 2014; 99: 798–800. doi: 10.1007/s12185-014-1555-5 - DOI - PubMed
    1. Ramsay LB, Stany MP, Edison JD, Bernstein SA, Schlegal KE, Hamilton CA. Gemcitabine-associated large vessel vasculitis presenting as fever of unknown origin. J Clin Rheumatol 2010; 16: 181–2. doi: 10.1097/RHU.0b013e3181df91ad - DOI - PubMed